Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TS-1 combination OD tablet specific use-results survey in postoperative gastric cancer
jRCT1080222542Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur in gastric cancer (GC), sponsored by Taiho Pharmaceutical Co., Ltd. Primary endpoint: Safety of TS-1 combination OD tablet. Started Jun 2014; status: completed.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT1080222542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080222542.